Biffi et al., 2014 - Google Patents
Left ventricular lead stabilization to retain cardiac resynchronization therapy at long term: when is it advisable?Biffi et al., 2014
View HTML- Document ID
- 671414438839608615
- Author
- Biffi M
- Bertini M
- Ziacchi M
- Diemberger I
- Martignani C
- Boriani G
- Publication year
- Publication venue
- Europace
External Links
Snippet
Aims Left ventricular (LV) lead dislodgement occurs in about 10.6% of patients in the first 12 months after cardiac resynchronization therapy defibrillator implantation, and causes lack of clinical improvement, repeated surgery, and predisposes to infective complications and …
- 238000009125 cardiac resynchronization therapy 0 title abstract description 52
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation, e.g. heart pace-makers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/04—Detecting, measuring or recording bioelectric signals of the body of parts thereof
- A61B5/0402—Electrocardiography, i.e. ECG
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Biffi et al. | Left ventricular lead stabilization to retain cardiac resynchronization therapy at long term: when is it advisable? | |
Jastrzębski et al. | Left bundle branch area pacing outcomes: the multicentre European MELOS study | |
Zucchelli et al. | Major cardiac and vascular complications after transvenous lead extraction: acute outcome and predictive factors from the ESC-EHRA ELECTRa (European Lead Extraction ConTRolled) registry | |
Lewis et al. | His bundle pacing: a new strategy for physiological ventricular activation | |
Carabelli et al. | European experience with a first totally leadless cardiac resynchronization therapy pacemaker system | |
Deharo et al. | Pathways for training and accreditation for transvenous lead extraction: a European Heart Rhythm Association position paper | |
Diemberger et al. | From lead management to implanted patient management: systematic review and meta-analysis of the last 15 years of experience in lead extraction | |
Neuzil et al. | Pacemaker and ICD lead extraction with electrosurgical dissection sheaths and standard transvenous extraction systems: results of a randomized trial | |
Sperzel et al. | First prospective, multi-centre clinical experience with a novel left ventricular quadripolar lead | |
Forleo et al. | Clinical and procedural outcome of patients implanted with a quadripolar left ventricular lead: early results of a prospective multicenter study | |
Forleo et al. | Left ventricular pacing with a new quadripolar transvenous lead for CRT: early results of a prospective comparison with conventional implant outcomes | |
Kutarski et al. | Effectiveness, safety, and long-term outcomes of non-powered mechanical sheaths for transvenous lead extraction | |
Oto et al. | Percutaneous extraction of cardiac pacemaker and implantable cardioverter defibrillator leads with evolution mechanical dilator sheath: a single-centre experience | |
Roque et al. | Electrical storm induced by cardiac resynchronization therapy is determined by pacing on epicardial scar and can be successfully managed by catheter ablation | |
Seifert et al. | Influence of pacing configurations, body mass index, and position of coronary sinus lead on frequency of phrenic nerve stimulation and pacing thresholds under cardiac resynchronization therapy | |
Aytemir et al. | Initial experience with the TightRail™ Rotating Mechanical Dilator Sheath for transvenous lead extraction | |
Segreti et al. | Procedural outcomes associated with transvenous lead extraction in patients with abandoned leads: an ESC-EHRA ELECTRa (European Lead Extraction ConTRolled) Registry Sub-Analysis | |
Mazzone et al. | Advanced techniques for chronic lead extraction: heading from the laser towards the evolution system | |
Duray et al. | Complications leading to surgical revision in implantable cardioverter defibrillator patients: comparison of patients with single-chamber, dual-chamber, and biventricular devices | |
Silvetti et al. | Subcutaneous implantable cardioverter-defibrillator: is it ready for use in children and young adults? A single-centre study | |
Chan et al. | Novel extravascular defibrillation configuration with a coil in the substernal space: the ASD clinical study | |
Tilz et al. | Management of ventricular tachycardia in the ablation era: results of the European Heart Rhythm Association Survey | |
Zucchelli et al. | Cardiac resynchronization therapy after coronary sinus lead extraction: feasibility and mid-term outcome of transvenous reimplantation in a tertiary referral centre | |
Jacheć et al. | Risk factors predicting complications of transvenous lead extraction | |
Pelargonio et al. | Safety and effectiveness of transvenous lead extraction in octogenarians |